Skip to main content
. 2018 Nov 14;12(2):269–281. doi: 10.1016/j.tranon.2018.09.015

Supplementary Figure 2.

Supplementary Figure 2

Three PDCs used in PDX models were selected for drug treatment.

Three patient-derived primary cells (14GS-076, 14GS-084, and 15GS-023) that were maintained in mice were selected for evaluating the anticancer effect of certain drugs. These PDXs maintained expression of CDK4 and MDM2 in their tumor tissues.